Northwest Biotherapeutics Inc (NWBO)
0.2901
0.00 (0.00%)
USD |
OTCM |
Nov 14, 15:59
Northwest Biotherapeutics Enterprise Value: 416.39M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 416.39M |
| November 12, 2024 | 431.93M |
| November 11, 2024 | 446.34M |
| November 08, 2024 | 428.74M |
| November 07, 2024 | 373.95M |
| November 06, 2024 | 371.33M |
| November 05, 2024 | 371.45M |
| November 04, 2024 | 363.12M |
| November 01, 2024 | 377.69M |
| October 31, 2024 | 385.43M |
| October 30, 2024 | 400.22M |
| October 29, 2024 | 393.92M |
| October 28, 2024 | 401.22M |
| October 25, 2024 | 414.51M |
| October 24, 2024 | 397.66M |
| October 23, 2024 | 392.67M |
| October 22, 2024 | 397.66M |
| October 21, 2024 | 394.85M |
| October 18, 2024 | 419.92M |
| October 17, 2024 | 417.88M |
| October 16, 2024 | 427.55M |
| October 15, 2024 | 421.38M |
| October 14, 2024 | 405.15M |
| October 11, 2024 | 418.88M |
| October 10, 2024 | 419.45M |
| Date | Value |
|---|---|
| October 09, 2024 | 410.27M |
| October 08, 2024 | 427.50M |
| October 07, 2024 | 428.99M |
| October 04, 2024 | 435.61M |
| October 03, 2024 | 429.49M |
| October 02, 2024 | 443.97M |
| October 01, 2024 | 453.83M |
| September 30, 2024 | 447.59M |
| September 27, 2024 | 453.96M |
| September 26, 2024 | 445.35M |
| September 25, 2024 | 458.08M |
| September 24, 2024 | 471.31M |
| September 23, 2024 | 464.19M |
| September 20, 2024 | 446.22M |
| September 19, 2024 | 447.59M |
| September 18, 2024 | 432.61M |
| September 17, 2024 | 434.99M |
| September 16, 2024 | 432.61M |
| September 13, 2024 | 457.74M |
| September 12, 2024 | 459.95M |
| September 11, 2024 | 432.61M |
| September 10, 2024 | 428.87M |
| September 09, 2024 | 422.63M |
| September 06, 2024 | 422.38M |
| September 05, 2024 | 422.63M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
103.89M
Minimum
Mar 18 2020
1.873B
Maximum
May 05 2022
732.04M
Average
720.14M
Median
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 3.432M |
| Palatin Technologies Inc | 13.74M |
| iBio Inc | 6.814M |
| Theriva Biologics Inc | -13.26M |
| Oragenics Inc | 2.142M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -17.87M |
| Revenue (Quarterly) | 0.51M |
| Total Expenses (Quarterly) | 17.97M |
| EPS Diluted (Quarterly) | -0.02 |
| Profit Margin (Quarterly) | -3.50K% |
| Earnings Yield | -27.58% |
| Normalized Earnings Yield | -26.13 |